Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Norcliffe Nominees Limited investment portfolio
Norcliffe Nominees Limited has made numerous investments in companies such as Smi Drug Discovery, Afon Technology, and 4d Medicine within the Healthcare & Life Sciences sector.
vc
Portfolio
4
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (4)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| 4d Medicine Ltd 4D Medicine Ltd develops and commercializes 4Degra®, a patented bioabsorbable polymer resin used to manufacture 3D-printed medical implants such as orthopaedic devices and soft tissue scaffolds. The company targets the global surgical and orthopaedic markets, with a current focus on securing FDA clearance for its initial product range in the United States. | Healthcare & Life Sciences | Confirmed | 2025-09-30 |
| Afon Technology Ltd | Healthcare & Life Sciences | Confirmed | 2025-08-31 |
Shareholding changes (7)
Norcliffe Nominees Limited's positions across portfolio companies2026
- A1 4,117,740 → 0
- A1 SHARES 0 → 4,553,727
2025
- ORDINARY 1,204,921 → 7,062,629